Success Stories: EB-1A Petition Approved in 11 Days for Senior Research and Development Biologist from India in the Field of Pharmacology (111 Citations)
Client’s Testimonial:
“My working experience with you is excellent. Even, I did not have confidence before that my profile is good enough for EB-1A. But your guidance helps me a lot. When I saw my petition letter (excellently written), I got a confidence that I have a good chance of approval. Thank you for all helps and all quick replies.”
On June 2nd, 2017, we received another EB-1A (Alien of Extraordinary Ability) approval for a Senior Research and Development Biologist in the Field of Pharmacology (Approval Notice).
General Field: Pharmacology
Position at the Time of Case Filing: Senior Research and Development Biologist
Country of Origin: India
Service Center: Texas Service Center (TSC)
State of Residence at the Time of Filing: Mississippi
Approval Notice Date: June 2nd, 2017
Processing Time: 11 Days (Premium Processing Requested)
Case Summary:
A senior research and development biologist from India hired North America Immigration Law Group (NAILG) to file an EB-1A (Alien of Extraordinary Ability) petition on his behalf. Just 11 days after his case was filed, TSC approved it.
A prominent professor, whose letter we included in our EB1A petition to the USCIS, had this to say about our client: “[Client’s] history, both in the lab and beyond it, is emblematic of a scientist who is leading the way in the advancement of his field. As such, [Client] is an irreplaceable member of the scientific community. As much as we have benefited from his research, we would feel the negative repercussions of his loss just as strongly.” This recommendation letter was presented alongside several others, all of which advocated for the approval of our client’s EB1A petition.
Besides these words of support, our client’s EB1A dossier contained ample evidence of his high standing in the field of pharmacology. For instance, we noted the 111 times his 12 publications were cited as well as the 8 times he judged the work of his peers. We also detailed his work on the development of assays for screening against leishmaniasis, the screening of plant extracts to find drugs against Trypanosoma brucei, and the study of molecular targets for anti-parasitic drugs.
Because we professionally presented the many advantages that our client’s work has for the United States, his I-140 EB1A was approved by the USCIS, propelling him one big step closer to the green card finish line. We congratulate our client and thank him for retaining our I-485 services to help him and his dependent adjust their status for permanent residence.